The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors
暂无分享,去创建一个
E Lasonder | Jurgen Müller | C. Hanemann | E. Lasonder | Magdalena | Vikram Sharma | E. Ercolano | L Zhou | J Lyons-Rimmer | S Ammoun | J Müller | V Sharma | E Ercolano | D Hilton | I Taiwo | M Barczyk | C O Hanemann | L. Zhou | D. Hilton | Lu Zhou | S. Ammoun | V. Sharma | I. Taiwo | J. Lyons-Rimmer | M. Barczyk | J. Müller | Ifeoluwatola Taiwo | Barczyk
[1] Henry C. Chang,et al. KSR, a novel protein kinase required for RAS signal transduction , 1995, Cell.
[2] Sylwia Ammoun,et al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma. , 2008, Cancer research.
[3] B. Li,et al. Terbinafine inhibits KSR1 and suppresses Raf-MEK-ERK signaling in oral squamous cell carcinoma cells. , 2013, Neoplasma.
[4] R. Kolesnick,et al. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. , 2003, Cancer research.
[5] D. Evans,et al. Neurofibromatosis type 2 (NF2): A clinical and molecular review , 2009 .
[6] I. Ellis,et al. KSR1 regulates BRCA1 degradation and inhibits breast cancer growth , 2014, Oncogene.
[7] Robert E. Lewis,et al. The Molecular Scaffold KSR1 Regulates the Proliferative and Oncogenic Potential of Cells , 2004, Molecular and Cellular Biology.
[8] Jonathan A. Cooper,et al. Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus , 2010, Cell.
[9] Robert E. Lewis,et al. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. , 2011, The American journal of pathology.
[10] H. Horvitz,et al. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans , 1995, Cell.
[11] C. Hanemann,et al. Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/β-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways. , 2011, Neoplasia.
[12] M. Hetman,et al. Role of Kinase Suppressor of Ras-1 in Neuronal Survival Signaling by Extracellular Signal-Regulated Kinase 1/2 , 2007, The Journal of Neuroscience.
[13] J. Downward. KSR: A novel player in the RAS pathway , 1995, Cell.
[14] D. Gutmann,et al. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Hanemann,et al. Activation of ERK, AKT and JNK signalling pathways in human schwannomas in situ , 2009, Histopathology.
[16] Jurgen Müller,et al. Compartmentalization of the MAPK scaffold protein KSR1 modulates synaptic plasticity in hippocampal neurons , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Min Han,et al. The C. elegans ksr-1 gene encodes a novel raf-related kinase involved in Ras-mediated signal transduction , 1995, Cell.
[18] C. Carroll,et al. The role of insulin‐like growth factors signaling in merlin‐deficient human schwannomas , 2012, Glia.
[19] L. Kluwe,et al. Isolation and Characterization of Schwann Cells from Neurofibromatosis Type 2 Patients , 1998, Neurobiology of Disease.
[20] C. Hanemann,et al. The p53/mouse double minute 2 homolog complex deregulation in merlin‐deficient tumours , 2015, Molecular oncology.
[21] D. Morrison,et al. KSR: a MAPK scaffold of the Ras pathway? , 2001, Journal of cell science.
[22] Robert E. Lewis,et al. Phosphorylation Regulates the Nucleocytoplasmic Distribution of Kinase Suppressor of Ras* , 2002, The Journal of Biological Chemistry.
[23] C. Hanemann. Magic but treatable? Tumours due to loss of merlin. , 2008, Brain : a journal of neurology.
[24] D. Morrison,et al. Proteomic analysis of scaffold proteins in the ERK cascade. , 2010, Methods in molecular biology.
[25] D. Morrison,et al. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. , 2001, Molecular cell.
[26] N. Ratner,et al. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells , 1998, Oncogene.
[27] T. Veenstra,et al. Protein Phosphatase 2A Positively Regulates Ras Signaling by Dephosphorylating KSR1 and Raf-1 on Critical 14-3-3 Binding Sites , 2003, Current Biology.
[28] C. Hanemann,et al. Pathological Adhesion of Primary Human Schwannoma Cells is Dependent on Altered Expression of Integrins , 2003, Brain pathology.
[29] C. Matthies,et al. Actin-Rich Protrusions and Nonlocalized GTPase Activation in Merlin-Deficient Schwannomas , 2007, Journal of neuropathology and experimental neurology.
[30] Deborah K. Morrison,et al. Signaling dynamics of the KSR1 scaffold complex , 2009, Proceedings of the National Academy of Sciences.
[31] C. Hanemann,et al. Differential gene expression between human schwannoma and control Schwann cells , 2006, Neuropathology and applied neurobiology.
[32] C. Hanemann,et al. Merlin, a multi‐suppressor from cell membrane to the nucleus , 2012, FEBS letters.
[33] Jonathan A. Cooper,et al. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. , 2014, Cancer cell.
[34] Chuay-Yeng Koo,et al. SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1 , 2013, British Journal of Cancer.
[35] C. Matthies,et al. Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244 , 2010, Neurobiology of Disease.
[36] T. Veenstra,et al. KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. , 2009, Molecular cell.